Hipolin Intrinsic Value
Hipolin intrinsic value. Hipolin (HIPOLIN) median intrinsic value is ₹23.40 from 7 valuation models (range ₹23–₹62), vs current price ₹78.00 — -70.0% downside (Trading Above Calculated Value), margin of safety -100.0%. For current market price and key ratios, visit Hipolin share price today.
HIPOLIN Valuation Methods Summary — DCF, Graham Number & P/E
Hipolin intrinsic value across 7 models vs current price ₹78.00 — upside/downside and value range per method. Browse Hipolin financial data for revenue, profit, balance sheet and cash flow data.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹23.40 | ₹18.72 - ₹28.08 | -70.0% | EPS: ₹0.16, Sector P/E: 12x |
| Book Value Method | asset | ₹23.33 | ₹21.00 - ₹25.66 | -70.1% | Book Value/Share: ₹23.33, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹42.67 | ₹38.40 - ₹46.94 | -45.3% | Revenue/Share: ₹53.33, P/S: 0.8x |
| Simple DCF (5Y) | dcf | ₹61.89 | ₹49.51 - ₹74.27 | -20.7% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹23.40 | ₹21.06 - ₹25.74 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹23.40 | ₹21.06 - ₹25.74 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| Graham Defensive Method | conservative | ₹23.40 | ₹21.06 - ₹25.74 | -70.0% | EPS: ₹0.16, BVPS: ₹23.33 |
HIPOLIN Intrinsic Value vs Market Price — All Valuation Models
Hipolin fair value range ₹23–₹62 vs current market price ₹78.00 across 7 valuation models. Analyse HIPOLIN promoter holding to track promoter, FII and institutional holdings.
HIPOLIN Intrinsic Value Analysis — Undervalued or Overvalued?
Hipolin median intrinsic value ₹23.40, current price ₹78.00 — Trading Above Calculated Value by 70.0%, margin of safety -100.0%.
What is the intrinsic value of HIPOLIN?
Based on our comprehensive analysis using 7 different valuation methods, the estimated intrinsic value of Hipolin (HIPOLIN) is ₹23.40 (median value). With the current market price of ₹78.00, this represents a -70.0% variance from our estimated fair value.
The valuation range spans from ₹23.33 to ₹61.89, indicating ₹23.33 - ₹61.89.
Is HIPOLIN undervalued or overvalued?
Based on our multi-method analysis, Hipolin (HIPOLIN) appears to be trading above calculated value by approximately 70.0%.
HIPOLIN Financial Health — Key Ratios vs Industry Benchmarks
Hipolin financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Asset Turnover Ratio | 1.60x | Industry Standard: 1.0x+ | Above 1.0x | Measures asset utilization efficiency |
HIPOLIN Cash Flow Quality — Operating & Free Cash Flow
Hipolin operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹2 Cr | ₹2 Cr | Positive Free Cash Flow | 8/10 |
| March 2025 | ₹-3 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-5 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹3 Cr | ₹2 Cr | Positive Free Cash Flow | 7/10 |